I had emailed Cynata yesterday (after the clinical trial approval announcement) about the pre-clinical animal trial and the final report and this is the reply Ross sent out:
"We expect to receive a final study report from UMass in due course. However, you can safely assume that the data package we submitted to the MHRA was sufficiently robust for that body to approve our clinical trial application."
Ann: UK Regulatory Authority Approves Cynata GvHD Clinical Trial-CYP.AX, page-33
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $1.705K | 8.654K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12792 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 32500 | 1 |
View Market Depth
| Last trade - 10.02am 30/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |